ANI PHARMACEUTICALS INC Cash And Cash Equivalents At Carrying Value

Quick Answer

ANI PHARMACEUTICALS INC reported Cash And Cash Equivalents At Carrying Value of $285.59 million for the year ending 2025.

  • ANI PHARMACEUTICALS INC showed an increase of +97.1% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from ANI PHARMACEUTICALS INC's annual report (Form 10-K), filed with the SEC on February 27, 2026.
  • XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 14 years of available data (2012 to 2025), ANI PHARMACEUTICALS INC's Cash And Cash Equivalents At Carrying Value has grown by 2,596,127.3%.
  • Historical annual values: Fiscal year 2025: $285.59 million | Fiscal year 2024: $144.86 million | Fiscal year 2023: $221.12 million | Fiscal year 2022: $48.23 million | Fiscal year 2021: $100.30 million | Fiscal year 2020: $7.86 million | Fiscal year 2019: $62.33 million | Fiscal year 2018: $43.01 million | Fiscal year 2017: $31.14 million | Fiscal year 2016: $27.37 million | Fiscal year 2015: $154.68 million | Fiscal year 2014: $169.04 million | Fiscal year 2013: $11.11 million | Fiscal year 2012: $11.0 thousand.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: